Finally, we asked whether VE-cadherin has functional significance in SCLC with respect to tumour growth kinetics, the intra-tumoural delivery and efficacy of cisplatin (used together with etoposide as SCLC standard of care). The gene discussed is CDH5; the disease is neoplasm.